Control of the Opening of mPTP by Ex Vivo Measurements on Permeabilized Muscle Fibers (COMMEF)
COMMEF
2 other identifiers
observational
40
1 country
1
Brief Summary
mPTP (Mitochondrial Permeability Transition Pore) is a channel formed by a protein complex integrated into the inner membrane of mitochondria. Its opening is related to the elevation of the intra-mitochondrial calcium concentration and will result in: a mitochondrial decoupling, a rupture of the metabolic gradient and the release of pro-apoptotic factors. The objective of this study is the development of a new ex vivo technique for characterizing mPTP by a dual measurement combining oxygraphy and fluorimetry on permeabilized skeletal muscle fibers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2019
CompletedFirst Posted
Study publicly available on registry
December 24, 2019
CompletedStudy Start
First participant enrolled
January 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedJanuary 22, 2020
January 1, 2020
10 months
December 20, 2019
January 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determination of the mPTP calcium sensitivity mPTP
The goal is to study the feasibility of a new method for the analysis of the calcium sensitivity of mPTP on non-phantomized permeabilized muscle fibers by coupled use of oxygen and fluorimetry techniques. Calcium quantity and time required to open mPTPs in permeabilized muscle fibers will be measured, in the presence or absence of ciclosporin A, observable by total inhibition of mitochondrial respiration (synonymous with release of NADH).
day 0
Secondary Outcomes (1)
Identification of mPTP opening discrimination factors
Day 0
Interventions
knee ligamentoplasty
Eligibility Criteria
Patients referred for a knee ligamentoplasty
You may qualify if:
- Patients aged over 18 ;
- Patients referred for a knee ligamentoplasty (DIDT technique) ;
- Patients who signed the non-opposition form after being informed ;
- Patients benefiting from or affiliated to a social security.
You may not qualify if:
- \- Patients under guardianship, curatorship or deprived of liberty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ruddy Richard
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2019
First Posted
December 24, 2019
Study Start
January 20, 2020
Primary Completion
November 1, 2020
Study Completion
February 1, 2021
Last Updated
January 22, 2020
Record last verified: 2020-01